Inactive Instrument
Decibel Therapeutics, Inc. Stock
Stocks
DBTX
US24343R1068
Biotechnology & Medical Research
| 1 day | -0.81% |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Landry
DFI | Director of Finance/CFO | 62 | 22/09/2023 |
Nouhad Husseini
PRN | Corporate Officer/Principal | - | 22/09/2023 |
Leonard Brooks
TRE | Treasurer | - | 22/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Nouhad Husseini
BRD | Director/Board Member | - | 22/09/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/09/23 | Issuer sale | Chief People Officer | 341,666 | 1.3598% | ||
| 25/09/23 | Issuer sale | Chief Development Officer | 476,647 | 1.8970% | ||
| 25/09/23 | Issuer sale | Director | 30,000 | 0.1194% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.81% | -3.73% | - | - | 124M | |
| -3.10% | -3.43% | +36.29% | +67.69% | 65.28B | |
| +0.33% | +0.33% | +10.16% | +78.07% | 54.57B | |
| +0.16% | +1.73% | +9.89% | +102.10% | 53.59B | |
| -0.13% | +2.09% | +25.76% | +51.97% | 45.03B | |
| -1.39% | -5.08% | +15.70% | +114.12% | 42.17B | |
| +1.37% | -5.20% | +221.31% | +901.24% | 39.42B | |
| -0.74% | -4.84% | +14.53% | +44.45% | 32.71B | |
| -2.70% | -7.34% | +23.17% | +0.36% | 24.01B | |
| +1.11% | +15.18% | +60.27% | +49.33% | 26.5B | |
| Average | -0.60% | +1.98% | +46.34% | +156.59% | 42.59B | |
| Weighted average by Cap. | -0.66% | +1.72% | +43.38% | +155.49% |
Employees
68
